Pharsight

1. List of Verquvo drug patents

Patent Number	Company	Patent Title	Patent Expiry
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US10736896	MERCK SHARP DOHME	Substituted 5-fluoro-1H-pyrazolopyridines and their use	May, 2031 (8 years from now)
US8420656	MERCK SHARP DOHME	Substituted 5-fluoro-1H-pyrazolopyridines and their use	May, 2031 (8 years from now)
US9604948	MERCK SHARP DOHME	Process for preparing substituted 5-fluoro-1H-pyrazolopyridines	Nov, 2032 (9 years from now)
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9993476	MERCK SHARP DOHME	Substituted 5-flouro-1H-pyrazolopyridines and their use	May, 2031 (8 years from now)
US8921377	MERCK SHARP DOHME	Substituted 5-fluoro-1H-pyrazolopyridines and their use	May, 2031 (8 years from now)
US11439642	MERCK SHARP DOHME	Substituted 5-fluoro-1H-pyrazolopyridines and their use	May, 2031 (8 years from now)

Exclusivity	Exclusivity Expiration
New Chemical Entity Exclusivity (NCE)	Jan 19, 2026

NCE-1 date: 2025-01-19

Market Authorisation Date: 19 January, 2021

Treatment: Reducing the risk of cardiovascular death and heart failure (hf) hospitalization following a hospitalization for hf or need for outpatient iv diuretics, in adults with symptomatic chronic hf and eject...

Dosage: TABLET;ORAL